Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women

British Journal of Cancer

Volumn 82, Issue 7, 2000, Pages 1348-1352

  Cuzick, J ^a   Terry, G ^a   Ho, L ^a   Monaghan, J ^c   Lopes, A ^c   Clarkson, P ^c   Duncan, I ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Cervical cancer; HLA; HPV

Indexed keywords

HLA ANTIGEN; VIRUS DNA;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0034015236     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1103     Document Type: Article

References (20)

1. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM and Wheeler CM (1994) HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6: 157-162
2. Bontkes HJ, Van Duin M, De Gruij TD, Duggan-Keen MF, Walboomers JMM, Stukart MJ, Verheijen RHM, Helmerhorst TJM, Meijer CJLM, Scheper RJ, Stevens FRA, Dyer PA, Sinnott P and Stern PL (1998) HPV16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV16 E6 sequence variants. Int J Cancer 78: 166-171
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 78-84
4. Cuzick J, Beverley E, Ho L, Terry G, Sapper K, Mielzynska I, Lorincz A, Chan W-K, Krausz P and Soutter P (1999) HPV testing in primary screening of older women. Br J Cancer 81: 554-558
5. Duggan-Keen MF, Keating PJ, Stevens FRA, Sinnott P, Snijders PLF, Walboomers JMM, Davidson S, Hunter RD, Dyer PA and Stern PL (1996) Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression. Eur J Immunogen 23: 275-284
6. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ and Manos MM (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169: 235-240
7. Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB and Carrington M (1998) Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States. Can Epidemiol Biomarkers Prev 7: 1035-1041
8. IARC (1995) Human papillomavirus IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 64. IARC: Lyon
9. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C and Singer A (1996) Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69: 364-368
10. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W and Kurman RJ (1992) Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obs Gynaecol 79: 328-337
11. Nindl I, Rindfleisch K, Lotz B, Schneider A and Durst (1999) Uniform distribution of HPV16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82: 203-207
12. Odunsi K, Terry G, Ho L, Bell J, Cuzick J and Ganesan TS (1996) Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer 67: 595-602
13. Sanjeevi CB, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Angstrom T, Dillner J and Lernmark A (1996) Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 68: 409-414
14. Terry G, Ho L and Cuzick J (1998) Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. Int J Cancer 73: 651-655
15. Wank R, Schendel DJ and Thomssen C (1992) HLA antigens and cervical cancer. Nature 356: 22-23
16. Wheeler CM, Yamada T, Hildesheim A and Jenison SA (1997) Human papillomavirus type 16 sequence variants; identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35: 11-19
17. Xi LF, Koustsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK and Kiviat NB (1997) Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89: 796-802
18. Yamada T, Wheeler CM, Halpern AL, Stewart ACM, Hildesheim A and Jenison SA (1995) Human papillomavirus type 16 variant lineages in United States populations characterised by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J Virol 69: 7743-7753
19. Zehbe I, Voglino G, Delius H, Wilander E and Tommasino M (1998a), Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352: 1441-1442
20. Zehbe I, Wilander E, Delius H, Tommasino M (1998b). Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58: S29-S33